Your browser doesn't support javascript.
loading
Surveillance of OXA-244-producing Escherichia coli and epidemiologic investigation of cases, Denmark, January 2016 to August 2019.
Hammerum, Anette M; Porsbo, Lone Jannok; Hansen, Frank; Roer, Louise; Kaya, Hülya; Henius, Anna; Møller, Karina Lauenborg; Justesen, Ulrik S; Søes, Lillian; Røder, Bent L; Thomsen, Philip K; Wang, Mikala; Søndergaard, Turid Snekloth; Holzknecht, Barbara Juliane; Østergaard, Claus; Kjerulf, Anne; Kristensen, Brian; Hasman, Henrik.
Afiliação
  • Hammerum AM; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Porsbo LJ; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Hansen F; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Roer L; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Kaya H; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Henius A; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Møller KL; Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
  • Justesen US; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Søes L; Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark.
  • Røder BL; Department of Clinical Microbiology, Zealand University Hospital, Slagelse, Denmark.
  • Thomsen PK; Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
  • Wang M; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
  • Søndergaard TS; Department of Clinical Microbiology, Hospital Sønderjylland, Sønderborg, Denmark.
  • Holzknecht BJ; Department of Clinical Microbiology, Herlev and Gentofte University Hospital, Herlev, Denmark.
  • Østergaard C; Department of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark.
  • Kjerulf A; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Kristensen B; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Hasman H; Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill ; 25(18)2020 05.
Article em En | MEDLINE | ID: mdl-32400363
BackgroundCarbapenemase-producing Escherichia coli are increasing worldwide. In recent years, an increase in OXA-244-producing E. coli isolates has been seen in the national surveillance of carbapenemase-producing organisms in Denmark.AimMolecular characterisation and epidemiological investigation of OXA-244-producing E. coli isolates from January 2016 to August 2019.MethodsFor the epidemiological investigation, data from the Danish National Patient Registry and the Danish register of civil registration were used together with data from phone interviews with patients. Isolates were characterised by analysing whole genome sequences for resistance genes, MLST and core genome MLST (cgMLST).ResultsIn total, 24 OXA-244-producing E. coli isolates were obtained from 23 patients. Among the 23 patients, 13 reported travelling before detection of the E. coli isolates, with seven having visited countries in Northern Africa. Fifteen isolates also carried an extended-spectrum beta-lactamase gene and one had a plasmid-encoded AmpC gene. The most common detected sequence type (ST) was ST38, followed by ST69, ST167, ST10, ST361 and ST3268. Three clonal clusters were detected by cgMLST, but none of these clusters seemed to reflect nosocomial transmission in Denmark.ConclusionImport of OXA-244 E. coli isolates from travelling abroad seems likely for the majority of cases. Community sources were also possible, as many of the patients had no history of hospitalisation and many of the E. coli isolates belonged to STs that are present in the community. It was not possible to point at a single country or a community source as risk factor for acquiring OXA-244-producing E. coli.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Infecção Hospitalar / Infecções Comunitárias Adquiridas / Escherichia coli / Infecções por Escherichia coli Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Infecção Hospitalar / Infecções Comunitárias Adquiridas / Escherichia coli / Infecções por Escherichia coli Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article